LPS would induce inflammation by activating nuclear factor-κB (NF-κB) pathway via Toll-like receptor 4 (TLR4) which exacerbates gut barrier dysfunction and promotes CRC development [68–70]. Here, NFKB1 is linked to colorectal carcinoma.